12:00 AM
 | 
Oct 17, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cancer
Melanoma 3-Phosphoinositide-dependent protein kinase-1 (PDPK1); BRAF Studies in...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >